A single dose of rasburicase in elderly patients with hyperuricaemia reduces serum uric acid levels and improves renal function

Bibliography

• Wallace KL, Riedel AA, Joseph-Ridge N, Wortmann R. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 2004;31:1582-7
   PubMed Web of Science ®Google Scholar
• Glynn RJ, Campion EW, Silbert JE. Trends in serum uric acid levels 1961–1980. Arthritis Rheum 1983;26:87-93
   PubMed Web of Science ®Google Scholar
• Roberts C, Homeida M, Roberts F. Effects of piretanide, bumetanide and furosemide on electrolyte and urate excretion in normal subjects. Br J Clin Pharmacol 1978;6:129-33
   PubMed Web of Science ®Google Scholar
• Ekbom T, Dalhof B, Hansson L, et al. Antihypertensive efficacy and side effects of three beta-blockers and a diuretic in elderly hypertensives: a report from the STOP-Hypertension study. J Hypertens 1992;10:1525-30
   PubMed Web of Science ®Google Scholar
• Reyes AJ. Cardiovascular drugs and serum uric acid. Cardiovascular Drug Therapy 2003;17:397-414
   Google Scholar
• Bieber JD, Terkeltaub RA. Gout: on the brink of novel therapeutic options for an ancient disease. Arthritis Rheum 2004;50:2400-14
   PubMed Web of Science ®Google Scholar
• Choi HK, Curhan G. Beer, liquor, and wine consumption and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2004;51:1023-9
   PubMed Web of Science ®Google Scholar
• Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003;41:1183-90
   PubMed Web of Science ®Google Scholar
• Nakanishi N, Okamoto M, Yoshida H, et al. Serum uric acid and risk for development of hypertension and impaired fasting glucose or type II diabetes in Japanese male office workers. Eur J Epidemiol 2003;18:523-30
   PubMed Web of Science ®Google Scholar
• Neogi T. Asymptomatic hyperuricemia: perhaps not so benign? Neogi T J Rheumatol 2008;35:734-7
   PubMedGoogle Scholar
• Pumo V, Sciacca D, Malaguarnera M. Tumor lysis syndrome in elderly. Crit Rev Oncol Hematol 2007;64:31-42
   PubMed Web of Science ®Google Scholar
• Rampello E, Fricia T, Malaguarnera M. The management of tumor lysis syndrome. Nat Clin Pract Oncol 2006;3:438-47
   PubMedGoogle Scholar
• Pui CH, Relling MV, Lascombs F, et al. Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies. Leukemia 1997;11:1813-16
   PubMed Web of Science ®Google Scholar
• Pui CH, Mahmoud HH, Wiley JM, et al. Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma. J Clin Oncol 2001;19:697-704
   PubMed Web of Science ®Google Scholar
• Patte C, Sakiroglu O, Sommelet D. European experience in the treatment of hyperuricemia. Semin Hematol 2001;38:9-12
   PubMed Web of Science ®Google Scholar
• World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997;277:925-6
   PubMed Web of Science ®Google Scholar
• McDonnel AM, Lenz KL, Frei-Lahr DA, et al. Single-dose rasburicase 6 mg in the management of tumor lysis syndrome in adults. Pharmacotherapy 2006;26:806-12
   PubMedGoogle Scholar
• Tietz NW. Clinical guide to laboratory tests. Second edition. Philadelphia: Saunders, 1990
   Google Scholar
• Hutcherson DA, Gammon DC, Bhatt MS, Faneuf M. Reduced-dose rasburicase in the treatment of adults with hyperuricemia associated with malignancy. Pharmacotherapy 2006;26:242-7
   PubMed Web of Science ®Google Scholar
• Trifilio S, Gordon L, Singhal S, et al. Reduced-dose rasburicase (recombinant xanthine oxidase) in adult cancer patients with hyperuricemia. Bone Marrow Transplant 2006;37:997-1001
   PubMed Web of Science ®Google Scholar
• Daskalopoulou SS, Tzovaras V, Mikhailidis DP, Elisaf M. Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemia. Curr Pharm Des 2005;11:4161-75
   PubMed Web of Science ®Google Scholar
• Andreoli SP, Clark JH, McGuire WA, et al. Purine excretion during tumor lysis in children with acute lymphocytic leucemia receiving allopurinol: relationship to acute renal failure. J Pediatr 1986;109:292-8
   PubMed Web of Science ®Google Scholar
• Bessmertny O, Robitaille LM, Cairo MS. rasburicase: a new approach for preventing and/or treating tumor lysis syndrome. Curr Pharm Des 2005;11:4177-85
   PubMed Web of Science ®Google Scholar
• Spector T. Inhibition of urate production by allopurinol. Biochem Pharmacol 1997;26:355-8
   Google Scholar
• Terkeltaub RA. Gout. N Engl J Med 2003;349:1647-55
   PubMed Web of Science ®Google Scholar
• Stamp L, Searle M, O'Donnel J, Chapman P. Gout in solid organ transplantation. a challenging clinical problem. Drugs 2005;65:2593-611
   PubMed Web of Science ®Google Scholar
• Schlesinger N. Management of acute and chronic gouty arthritis; present state-of-the-art. Drugs 2004;64:2399-416
   PubMed Web of Science ®Google Scholar
• Goldman SC, Holcenberg JS, Finklestein JZ, et al. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood 2001;97:2998-3003
   PubMed Web of Science ®Google Scholar
• Band PR, Silverberg DS, Henderson JF, et al. Xanthine nephropathy in a patient with lymphosarcoma treated with allopurinol. N Engl J Med 1970;283:354-7
   PubMed Web of Science ®Google Scholar
• Ablin A, Stephens BG, Hirata T, et al. Nephropathy, xanthinuria, and orotic aciduria complicating Burkitt's lymphoma treated with chemotherapy and allopurinol. Metabolism 1972;21:771-8
   PubMed Web of Science ®Google Scholar
• Cammalleri L, Malaguarnera M. rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout. Int J Med Sci 2007;4:83-93
   PubMedGoogle Scholar
• Johnson RJ, Segal MS, Srinivas T, et al. Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link? J Am Soc Nephrol 2005;16:1909-19
   PubMed Web of Science ®Google Scholar
• Baker JF, Krishnan E, Chen L, Schumacher HR. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med 2005;118:816-26
   PubMed Web of Science ®Google Scholar
• Bos MJ, Koudstaal PJ, Hofman A, et al. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 2006;37:1503-7
   PubMed Web of Science ®Google Scholar